Loading...
OTCM
VRAYQ
Market cap479mUSD
May 30, Last price  
0.00
1D
0.00%
1Q
0.00%
IPO
-100.00%
Name

ViewRay Inc

Chart & Performance

D1W1MN
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
25.32%
Rev. gr., 5y
24.59%
Revenues
102m
+45.76%
3,159,000010,390,00022,237,00034,042,00080,962,00087,782,00057,017,00070,119,000102,206,000
Net income
-108m
L+1.32%
-27,222,0000-44,995,000-50,636,000-72,176,000-76,396,000-123,073,000-105,381,000-106,134,000-107,533,000
CFO
-92m
L+47.70%
-25,371,000-24,349-39,849,000-28,156,000-70,053,000-122,194,000-79,567,000-63,474,000-62,091,000-91,708,000

Profile

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.
URL
https://viewray.com/
IPO date
Nov 04, 2014
Employees
295
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
102,206
45.76%
Cost of revenue
207,517
Unusual Expense (Income)
NOPBT
(105,311)
NOPBT Margin
Operating Taxes
203
Tax Rate
NOPAT
(105,514)
Net income
(107,533)
1.32%
Dividends
Dividend yield
Proceeds from repurchase of equity
79
BB yield
-0.01%
Debt
Debt current
2,860
Long-term debt
91,609
Deferred revenue
3,069
Other long-term liabilities
5,960
Net debt
(41,491)
Cash flow
Cash from operating activities
(91,708)
CAPEX
(3,898)
Cash from investing activities
(3,898)
Cash from financing activities
18,293
FCF
(101,197)
Balance
Cash
135,960
Long term investments
Excess cash
130,850
Stockholders' equity
(842,656)
Invested Capital
1,018,671
ROIC
ROCE
EV
Common stock shares outstanding
180,697
Price
4.48
-18.69%
Market cap
809,524
-10.70%
EV
768,033
EBITDA
(100,389)
EV/EBITDA
Interest
5,057
Interest/NOPBT